EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enumeration and Characterization of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

María L Espejo-Cruz, Sandra González-Rubio, Juan J Espejo iD, Javier M Zamora-Olaya iD, Rafael M Alejandre-Altamirano iD, María Prieto-Torre, Clara I Linares, Marta Guerrero-Misas, Pilar Barrera-Baena, Antonio Poyato-González, Marina Sánchez-Frías, María D Ayllón und 3 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24032558 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von María L Espejo-Cruz und 14 weiteren Autor:innen. Beteiligte Einrichtung: Maimonides Biomedical Research Institute of Córdoba (IMIBIC), University of Córdoba, 14004 Cordoba, Spain. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Neoplastic Cells, Circulating, Liver Neoplasms, Chemoembolization, Therapeutic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Regional Government of Andalusia, Plan Nacional de I+D+I Proyectos de Investigación en Salud of Instituto de Salud Carlos III (ISCIII), Subdirección General de Evaluación and Fondo Europeo de D….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Circulating tumor cells (CTCs), and particularly circulating cancer stem cells (cCSC), are prognostic biomarkers for different malignancies and may be detected using liquid biopsies. The ex vivo culture of cCSCs would provide valuable information regarding biological aggressiveness and would allow monitoring the adaptive changes acquired by the tumor in real time. In this prospective pilot study, we analyzed the presence of EpCAM+ CTCs using the IsoFlux system in the peripheral blood of 37 patients with hepatocellular carcinoma undergoing transarterial chemoembolization (TACE). The average patient age was 63.5 ± 7.9 years and 91.9% of the patients were men. All patients had detectable CTCs at baseline and 20 patients (54.1%) showed CTC aggregates or clusters in their peripheral blood. The increased total tumor diameter (OR: 2.5 (95% CI: 1.3–4.8), p = 0.006) and the absence of clusters of CTCs at baseline (OR: 0.2 (95% CI: 0.0–1.0), p = 0.049) were independent predictors of a diminished response to TACE. Culture of cCSC was successful in five out of thirty-three patients, mostly using negative enrichment of CD45− cells, ultra-low adherence, high glucose, and a short period of hypoxia followed by normoxia. In conclusion, the identification of clusters of CTCs before TACE and the implementation of standardized approaches for cCSC culture could aid to predict outcomes and to define the optimal adjuvant therapeutic strategy for a true personalized medicine in hepatocellular carcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularNeoplastic Cells, CirculatingLiver NeoplasmsChemoembolization, TherapeuticMaleHumansMiddle AgedAgedFemaleProspective StudiesPilot ProjectsBiomarkers, Tumor

Stichwörter der Autor:innen

circulating cancer stem cellscirculating tumor cellshepatocellular carcinomaliquid biopsyspheroidstransarterial chemoembolization

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Maimonides Biomedical Research Institute of Córdoba (IMIBIC), University of Córdoba, 14004 Cordoba, Spain.
  • Biomedical Research Network Center for Liver and Digestive Diseases (CIBERehd), 28029 Madrid, Spain.
  • Department of Interventional Radiology, Reina Sofia University Hospital, 14004 Cordoba, Spain.
  • Department of Hepatology and Liver Transplantation, Reina Sofia University Hospital, 14004 Cordoba, Spain.
  • Department of Pathology, Reina Sofia University Hospital, 14004 Cordoba, Spain.
  • Department of Hepatobiliary Surgery and Liver Transplantation, Reina Sofia University Hospital, 14004 Cordoba, Spain.

ORCID-Profile: Juan J Espejo, Javier M Zamora-Olaya, Rafael M Alejandre-Altamirano, Manuel L Rodríguez-Perálvarez

Förderung

  • Instituto de Salud Carlos III
  • Regional Government of Andalusia
  • Plan Nacional de I+D+I Proyectos de Investigación en Salud of Instituto de Salud Carlos III (ISCIII), Subdirección General de Evaluación and Fondo Europeo de D…
  • CIBERehd
  • Consejería de Salud y Familias de la Junta de Andalucía and Fondo Social Europeo
  • ISCIII

Zitieren

APA

Espejo-Cruz, M. L., González-Rubio, S., Espejo, J. J., Zamora-Olaya, J. M., Alejandre-Altamirano, R. M., Prieto-Torre, M., Linares, C. I., Guerrero-Misas, M., Barrera-Baena, P., Poyato-González, A., Sánchez-Frías, M., Ayllón, M. D., Rodríguez-Perálvarez, M. L., de la Mata, M., & Ferrín, G. (2023). Enumeration and Characterization of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032558

Vancouver

Espejo-Cruz ML, González-Rubio S, Espejo JJ, Zamora-Olaya JM, Alejandre-Altamirano RM, Prieto-Torre M, et al. Enumeration and Characterization of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032558

BibTeX
@article{EspejoCruz2023,
  author = {Espejo-Cruz, María L and González-Rubio, Sandra and Espejo, Juan J and Zamora-Olaya, Javier M and Alejandre-Altamirano, Rafael M and Prieto-Torre, María and Linares, Clara I and Guerrero-Misas, Marta and Barrera-Baena, Pilar and Poyato-González, Antonio and Sánchez-Frías, Marina and Ayllón, María D and Rodríguez-Perálvarez, Manuel L and de la Mata, Manuel and Ferrín, Gustavo},
  title = {Enumeration and Characterization of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24032558}
}
Kostenlos starten →